During the past decade, Dr. Jeffrey Chen conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dr. Jeffrey Chen" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Dr. Jeffrey Chen" are "Hypertension" (2 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Dr. Jeffrey Chen" in a lesser frequency.

Most popular intervention types in "Dr. Jeffrey Chen" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (2 trials), "Guanfacine" (2 trials), "Acetylsalicylic acid" (1 trials), "Apixaban" (1 trials) and "Darusentan Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr. Jeffrey Chen" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Dr. Jeffrey Chen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dr. Jeffrey Chen, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dr. Jeffrey Chen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".